Cancer Genetics Inc (NASDAQ:CGIX)

8.66
Delayed Data
As of Mar 03
 -0.10 / -1.14%
Today’s Change
4.83
Today|||52-Week Range
19.99
+29.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-8.4M-19.9M-6.7M-12.4M
 
 
 
 
 
Depreciation326.8K369.7K353.4K326.5K
 
 
 
 
 
Total Other Cash Flow3.2M13.0M-973.8K5.8M
 
 
 
 
 
Funds From Operations-4.9M-6.5M-7.3M-6.3M
 
 
 
 
 
Funds From/For Other Operating Expenses834.2K-1.4M291.8K1.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.7M-5.1M-7.6M-8.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-1.0M
 
 
Capital Expenditures-161.2K-268.6K-162.5K-257.3K
 
 
 
 
 
Other Investing - Uses0.000.00-50.0K-50.0K
 
 
 
Other Investing - Sources11.6K238.4K0.00--
 
 
 
Net Cash Flow Investing-168.0K-113.1K-347.8K-1.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings590.0K6.2M7.1M0.00
 
 
 
 
Long Term Debt Reduction-1.2M-242.7K-54.0K-3.6M
 
 
 
 
 
Net Proceeds Stock Sale8.3M-132.9K-737.8K61.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.6M5.8M6.3M58.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash------0.00--
 
Net Change In Cash1.7M638.0K-1.6M48.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account